Copper‐Catalyzed Stereoselective Direct Olefinic β‐C(sp 2 )−H Imidation of Acyclic Enamides with NFSI
Chinese Journal of Chemistry · 15.09.2025 · 43 (18) · 2347-2352
DOI: 10.1002/cjoc.70118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chinese Journal of Chemistry, online erschienen am 10.06.2025. Verfasst von Guisheng Chen und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangxi Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Comprehensive Summary Herein, we reported a copper‐catalyzed stereoselective olefinic β‐C(sp 2 )–H imidation of acyclic enamides employing commercially available N ‐fluorobenzenesulfonimide (NFSI) as an imidating reagent, which allows for the synthesis of various imidation products with mainly E ‐selective control. This methodology was featured by being ligand‐free, having good efficacy, and exhibiting broad substrate scope for acyclic enamides. Mechanistically, the imidyl radical species might be involved in the reaction.
Förderung
- Natural Science Foundation of Jiangxi Province
- National Natural Science Foundation of China
Zitieren
APA
Chen, G., Li, X., Liu, J., Liu, H., & Luo, H. (2025). Copper‐Catalyzed Stereoselective Direct Olefinic β‐C(sp 2 )−H Imidation of Acyclic Enamides with NFSI. Chinese Journal of Chemistry, 43(18), 2347-2352. https://doi.org/10.1002/cjoc.70118
Vancouver
Chen G, Li X, Liu J, Liu H, Luo H. Copper‐Catalyzed Stereoselective Direct Olefinic β‐C(sp 2 )−H Imidation of Acyclic Enamides with NFSI. Chinese Journal of Chemistry. 2025;43(18):2347-2352. doi:10.1002/cjoc.70118
BibTeX
@article{Chen2025,
author = {Chen, Guisheng and Li, Xiaolan and Liu, Jie and Liu, Haidong and Luo, Haiqing},
title = {Copper‐Catalyzed Stereoselective Direct Olefinic β‐C(sp 2 )−H Imidation of Acyclic Enamides with NFSI},
journal = {Chinese Journal of Chemistry},
year = {2025},
volume = {43},
number = {18},
pages = {2347--2352},
doi = {10.1002/cjoc.70118}
}
EUVIMED